Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil

Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil

Objective: Characterising the perceptions of teams most affected by HIV is prime in establishing pointers for biomedical development. Although Brazil has efficiently fought HIV/AIDS by a number of measures, transgender women nonetheless have a chance of HIV an infection 55 instances increased than the overall inhabitants. This research aimed to higher perceive the notion and consciousness of HIV cure research among the trans-identifying inhabitants in São Paulo, Brazil, and to find out components that inspire or discourage participation in HIV cure research.Setting: This cross-sectional research analysed information collected from a questionnaire administered to 118 transgender women and travestis at 5 websites throughout the metropolis of São Paulo. It makes use of quantitative methodology to explain the views of transgender and travesti folks in relation to HIV cure research and the context in which such views are produced.

Results: Of 118 members, most members (73%) had some data of HIV cure research and had been most keen to take part in on-line surveys (52%), interviews (52%), focus teams (52%) and research involving blood attracts (57%). Those with a increased training or employment standing had been extra more likely to agree that somebody had been cured of HIV, folks residing with HIV are discriminated in opposition to, and extra details about HIV cure research is required earlier than the group embraces it. Only 55% of members fully trusted their doctor. The largest motivational components included gaining further data about HIV an infection (77%) and the potential for a longer, more healthy life for all (73%).

Conclusions: As a main evaluation of HIV cure attitudes among the transgender and travesti inhabitants in addition to the social context in which they’re shaped, this research identifies alternatives to strengthen the dialogue and develop extra academic collaborations between scientific investigators, group educators and the trans-identifying inhabitants to make sure that HIV cure research is inclusive of various views. mplementation of efficient behavioral research methods among HIV at-risk and contaminated AYA is vital to ending the HIV epidemic and necessitates profitable recruitment methods. A complete search was executed throughout 4 digital databases. Of the 1697 recognized research, seven met inclusion standards with six of those seven directed to HIV prevention. Most research used on-line recruitment as a part of a hybrid technique, and mixed field-based/in-person and on-line strategies. Recruitment methods and outcomes, assets and compensation, procedures for consent, and timelines different among all seven research. Our outcomes spotlight the necessity for growth of recruitment fashions in alignment with behavioral methods aimed to deal with and forestall HIV among US AYA.

Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil
Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil

Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study

Background: Longitudinal follow-up of older individuals residing with HIV is important for the ascertainment of aging-related scientific and behavioral outcomes, and self-administered questionnaires are crucial for gathering behavioral data in research involving individuals residing with HIV. Web-based self-reported information assortment outcomes in increased information high quality than paper-and-pencil questionnaires in a wide selection of populations. The possibility of distant web-based surveys may additionally improve retention in long-term research research. However, the acceptability and feasibility of web-based information assortment in scientific research involving older individuals residing with HIV have by no means been studied.

Objective: This research goals to evaluate the acceptability and feasibility of a web-based survey to gather data on sexual, substance use, and bodily exercise behaviors; examine the information high quality of the web-based survey with that of a paper-and-pencil questionnaire; and summarize web-based survey metrics.

Methods: This pilot research came about throughout the AIDS Clinical Trials Group A5322 research, a longitudinal cohort of males and women residing with HIV (aged ≥40 years), adopted at 32 scientific websites in the United States and Puerto Rico. A complete of four websites participated in this research. An internet-based survey was created utilizing self-administered questionnaires sometimes accomplished in A5322 through paper and pencil. Pilot research members accomplished these questionnaires through web-based survey at one research go to in lieu of paper-and-pencil administration. Two questions had been added to evaluate feasibility, outlined as members’ notion of the convenience of web-based survey completion (very arduous, arduous, straightforward, very straightforward), and their most well-liked format (pc or pill, paper and pencil, no choice) for finishing the questions in the longer term (acceptability). Feasibility and acceptability had been summarized total and by demographic and scientific traits; the proportion of evaluable information by web-based survey versus beforehand administered paper-and-pencil questionnaires (information high quality) was in contrast for every query.

Rat IgG2a Isotype Control

abx405045-05mg 0.5 mg
EUR 384

Rat IgG2a Isotype Control

20-abx405047
  • EUR 300.00
  • EUR 439.00
  • 0.1 mg
  • 1 mg

Rat IgG2a Isotype Control

abx200644-500ug 500 ug
EUR 481

Rat IgG2a Isotype Control

RIGG2AA-100 100 µg
EUR 312.08

Rat IgG2a Isotype Control

RIGG2AA-25 25 µg
EUR 181.04

Rat IgG2a Isotype Control

RIGG2AB-200 200 µg
EUR 457.68

Rat IgG2a Isotype Control

RIGG2AB-50 50 µg
EUR 224.72

Rat IgG2a Isotype Control

RIGG2AF-200 200 µg
EUR 312.08

Rat IgG2a Isotype Control

RIGG2AF-50 50 µg
EUR 166.48

Rat IgG2a Isotype Control

RIGG2APE-100 100 µg
EUR 282.96

Rat IgG2a Isotype Control

RIGG2APE-25 25 µg
EUR 166.48

Rat IgG2a Isotype Control

RIGG2APP-100 100 µg
EUR 574.16

Rat IgG2a Isotype Control

RIGG2APP-25 25 µg
EUR 268.4

Rat IgG2a Isotype Control

RIGG2APP5.5-100 100 µg
EUR 646.96

Rat IgG2a Isotype Control

RIGG2APP5.5-25 25 µg
EUR 282.96

Rat IgG2a Isotype Control

RIGG2APU-50 50 µg
EUR 181.04

Rat IgG2a Isotype Control

RIGG2APU-500 500 µg
EUR 399.44

Rat IgG2a unconjugated (isotype control)

20005-12 100 ug
EUR 164

Rat IgG2a Isotype Control Purified

11-168-C100 0.1 mg
EUR 136

Rat IgG2a Isotype Control PE

1P-168-C025 0.025 mg
EUR 122

Rat IgG2a Isotype Control PE

1P-168-C100 0.1 mg
EUR 204

Rat IgG2a Isotype Control (Biotin)

abx405023-01mg 0.1 mg
EUR 314

Rat IgG2a Isotype Control (FITC)

abx405025-100tests 100 tests
EUR 342

Rat IgG2a Isotype Control (RPE)

abx405026-100tests 100 tests
EUR 356

Rat IgG2a Isotype Control (APC)

abx405043-100tests 100 tests
EUR 425

Rat IgG2a Isotype Control (Biotin)

abx405044-01mg 0.1 mg
EUR 314

Rat IgG2a Isotype Control (FITC)

abx405046-01mg 0.1 mg
EUR 342

Rat IgG2a Isotype Control (RPE)

abx405048-100tests 100 tests
EUR 356

Mouse IgG2a Isotype Control

abx139004-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control

abx139005-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control

abx139009-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control

abx405013-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control

abx405015-05mg 0.5 mg
EUR 690

Mouse IgG2a Isotype Control

abx405018-1mg 1 mg
EUR 1107

Mouse IgG2a Isotype Control

abx405070-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control

abx405073-05mg 0.5 mg
EUR 829

Mouse IgG2a Isotype Control

abx200572-100ug 100 ug
EUR 314

Mouse IgG2a Isotype Control

10R-I117d 1 mg
EUR 553
Description: Purified Mouse IgG2a Isotype Control

Rat IgG2a (FITC) / Rat IgG2a (RPE) Isotype Control

abx405004-100tests 100 tests
EUR 634

Rat IgG2a-APC conjugate (isotype control)

20005-12-APC 25 tests
EUR 202

Rat IgG2a-Biotin conjugate (isotype control)

20005-12-B 100 ug
EUR 202

Rat IgG2a-FITC conjugate (isotype control)

20005-12-F 100 ug
EUR 225

Rat IgG2a-HRP conjugate (isotype control)

20005-12-HP 100 ug
EUR 202

Rat IgG2a Isotype Control LOW ENDOTOXIN

12-168-C100 0.1 mg
EUR 136

Mouse IgG2a Isotype Control PerCP

PC-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control PerCP

PC-724-C100 0.1 mg
EUR 204

Mouse IgG2a isotype control, purified

20102-102 100 ug
EUR 141

Mouse IgG2a Isotype Control Purified

11-458-C025 0.025 mg
EUR 88

Mouse IgG2a Isotype Control Purified

11-458-C100 0.1 mg
EUR 136

Mouse IgG2a Isotype Control Purified

11-724-C025 0.025 mg
EUR 88

Mouse IgG2a Isotype Control Purified

11-724-C100 0.1 mg
EUR 136

Mouse IgG2a Isotype Control APC

1A-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control APC

1A-724-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control Biotin

1B-724-C025 0.025 mg
EUR 108

Mouse IgG2a Isotype Control Biotin

1B-724-C100 0.1 mg
EUR 177

Mouse IgG2a Isotype Control FITC

1F-724-C025 0.025 mg
EUR 108

Mouse IgG2a Isotype Control FITC

1F-724-C100 0.1 mg
EUR 177

Mouse IgG2a Isotype Control PE

1P-724-C025 0.025 mg
EUR 122

Mouse IgG2a Isotype Control PE

1P-724-C100 0.1 mg
EUR 204

Mouse IgG2a Isotype Control (Biotin)

abx139013-01mg 0.1 mg
EUR 384

Mouse IgG2a Isotype Control (PE)

abx139015-01mg 0.1 mg
EUR 425

Mouse IgG2a Isotype Control (APC)

abx139012-01mg 0.1 mg
EUR 425

Mouse IgG2a Isotype Control (FITC)

abx139014-01mg 0.1 mg
EUR 384

Mouse IgG2a Isotype Control (PerCP)

abx139016-01mg 0.1 mg
EUR 425

Mouse IgG2a Isotype Control (Biotin)

abx405014-01mg 0.1 mg
EUR 411

Mouse IgG2a Isotype Control (FITC)

abx405016-01mg 0.1 mg
EUR 509

Mouse IgG2a Isotype Control (RPE)

abx405017-100tests 100 tests
EUR 634

Mouse IgG2a Isotype Control (APC)

abx405071-100tests 100 tests
EUR 425

Mouse IgG2a Isotype Control (Biotin)

abx405072-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control (FITC)

abx405074-100tests 100 tests
EUR 411

Mouse IgG2a Isotype Control (RPE)

abx405075-100tests 100 tests
EUR 467

Mouse IgG2a Isotype Control (FITC)

abx200573-100ug 100 ug
EUR 314

Mouse IgG2a Isotype Control (PE)

abx200574-50ug 50 ug
EUR 425

Mouse IgG2a Isotype Control (APC)

abx200575-50ug 50 ug
EUR 425

Mouse IgG2a Isotype Control (PerCP)

abx200576-100ug 100 ug
EUR 425

Mouse IgG2a Isotype control; Concentrate

NG905C 1 ml
EUR 357

Mouse IgG2a FITC (isotype control)

MG2bF-25 25 Tests
EUR 225

Rat IgG2a-R-PE conjugate (isotype control)

20005-12-PE 25 tests
EUR 202

Rat IgG2a Isotype Control (2A3), Untagged-100ug

QAB64-100ug 100ug
EUR 131

Rat IgG2a Isotype Control (2A3), APC-100ug

QAB64-APC-100ug 100ug
EUR 208

Rat IgG2a Isotype Control (2A3), FITC-100ug

QAB64-F-100ug 100ug
EUR 141

Rat IgG2a Isotype Control (2A3), PE-100ug

QAB64-PE-100ug 100ug
EUR 191

Rat IgG2a Isotype Control (2A3), V450-100ug

QAB64-V450-100ug 100ug
EUR 216

Mouse IgG2a (FITC) / Mouse IgG2a (RPE) Isotype Control

abx405002-50tests 50 tests
EUR 620

Mouse IgG2a Isotype Control Pacific Blue

PB-724-C025 0.025 mg
EUR 139

Mouse IgG2a Isotype Control Pacific Blue

PB-724-C100 0.1 mg
EUR 238

Mouse IgG2a-Biotin conjugate (isotype control)

20102-102-B 50 Tests
EUR 164

Mouse IgG2a-FITC conjugate (isotype control)

20102-102-F 50 tests
EUR 164

Mouse IgG2a-HRP conjugate (isotype control)

20102-102-HP 50 Tests
EUR 164

Mouse IgG2a-PE conjugate (isotype control)

20102-102-PE 50 Tests
EUR 164

Mouse IgG2a Isotype Control (Azide free)

abx139007-01mg 0.1 mg
EUR 314

Mouse IgG2a Isotype Control Alexa Fluor488

A4-458-C025 0.025 mg
EUR 149

Mouse IgG2a Isotype Control Alexa Fluor488

A4-458-C100 0.1 mg
EUR 258

Mouse IgG2a Isotype Control Alexa Fluor488

A4-724-C025 0.025 mg
EUR 149

Mouse IgG2a Isotype Control Alexa Fluor488

A4-724-C100 0.1 mg
EUR 258

Mouse IgG2a Isotype Control Alexa Fluor647

A6-458-C025 0.025 mg
EUR 149

Results: Acceptability and feasibility had been excessive total: 50.0% (79/158) most well-liked pc or pill, 38.0% (60/158) reported no choice, and 12.0% (19/158) most well-liked paper and pencil; 93.0% (147/158) reported survey completion straightforward or very straightforward. Older age was associated with decrease odds of preferring pc or pill to paper and pencil (odds ratio per 1-year improve in age: 0.91, 95% CI 0.85-0.98). Individuals who discovered the survey arduous or very arduous had a decrease median neurocognitive take a look at rating than those that discovered it straightforward or very straightforward. Data high quality with web-based survey administration was much like or increased than that with paper-and-pencil administration for many questions.Conclusions: Web-based survey administration was acceptable and possible in this cohort of older adults residing with HIV, and information high quality was excessive. Web-based surveys will be a great tool for legitimate information assortment and can probably enhance retention in long-term follow-up research.